Explain this page
Arphra AIPlain-English read on Innoviva, Inc.’s valuation06-16today
- Nortiva Bio Launches to Develop Long-Acting Oral Medicines7d
- Nortiva Bio Launches to Develop Long-Acting Oral Medicines7d
- Nortiva Bio Launches to Develop Long-Acting Oral Medicines7d
- Innoviva Specialty Therapeutics Announces Distribution and Licensing Agreement with Dr. Reddy's for XACDURO® in Select International Markets9d
AI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
—
— vs spot
Recommendation
n/a
0 of 0 methods
Method spread
0bull0bear
±5% threshold
Analyst PT consensus: $37.00 (+56.51%)
Candlestick · 1Y
Open in chart workstation →INVA
22.49+7.20%H 25.15L 19.81MA50 22.47MA200 —Avg vol 853K
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.38% | +5.39% | +4.23% | +4.65% | +19.39% | +18.26% | +15.43% | +87.03% | +75.11% | +138.55% | +74.30% |
Insider · 30d
History →Bought
$0
0 txns
Sold
$0
0 txns
Net flow
+$0
Aftermarket
LiveLast trade
$24.09
Bid
$21.50
396 sh
Ask
$24.30
50 sh
Spread
$2.800
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|
Sector & industry today
LiveSectors
- Consumer Cyclical+1.37%
- Technology+1.17%
- Utilities+0.96%
- Financial Services+0.65%
- Basic Materials+0.59%
- Industrials+0.54%
- Consumer Defensive+0.42%
- Energy-0.18%
- Communication Services-0.40%
- Healthcare-0.41%
- Real Estate-0.54%
Top industries (issuer's industry highlighted)
- Biotechnology+9.63%
- Software - Services-7.11%
- Business Equipment & Supplies+6.51%
- Financial - Mortgages+4.52%
- Furnishings, Fixtures & Appliances+4.34%
- Home Improvement+3.89%
- Construction+3.62%
- Paper, Lumber & Forest Products+3.53%
- Discount Stores+3.53%
- Medical - Diagnostics & Research+3.31%
- Financial - Conglomerates+3.03%
- REIT - Hotel & Motel+2.92%
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
News
DB · news_items- Nortiva Bio Launches to Develop Long-Acting Oral Medicinesgurufocus.com·Jun 18, 2026
- Nortiva Bio Launches to Develop Long-Acting Oral Medicinesbusinesswire.com·Jun 18, 2026
- Nortiva Bio Launches to Develop Long-Acting Oral Medicinesbusinesswire.com·Jun 18, 2026
- Innoviva Specialty Therapeutics Announces Distribution and Licensing Agreement with Dr. Reddy's for XACDURO® in Select International Marketsbusinesswire.com·Jun 16, 2026
- Innoviva Specialty Therapeutics Announces Distribution and Licensing Agreement with Dr. Reddy's for XACDURO® in Select International Marketsbusinesswire.com·Jun 16, 2026
- Innoviva, Inc. (INVA) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcriptseekingalpha.com·Jun 08, 2026
Recent analyst activity
DB- Jun 22, 2026GradeBuy → BuyH.C. Wainwright Reiterates Buy Rating on Inova Technology, Inc. (INVA)UBS
Peers
No peer list available for INVA.
Total assets
—
Total debt
—
Cash & equiv
—
Operating CF
—
Free cash flow
—
Buybacks
—
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| No open-market insider activity in the recent window. | ||||
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|